ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 910

The Cost-Effectiveness of Total Joint Arthroplasty: A Systematic Review of Published Literature

Meghan E. Daigle1, Alexander M. Weinstein1, Jeffrey N. Katz2 and Elena Losina1, 1Orthopaedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, 2Rheumatology and Orthopedics, Brigham and Women's Hospital, Boston, MA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Economics, osteoarthritis and total joint replacement

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Health Services Research: Epidemiology and Outcomes of Rheumatic Disease II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Utilization of total hip arthroplasty (THA) and total knee arthroplasty (TKA) has nearly doubled in the last decade.  These procedures are increasingly performed in younger, more active individuals. We sought to summarize the state of the literature evaluating the cost-effectiveness of these highly efficacious, costly procedures and identify areas where further work is needed.

Methods: We conducted a systematic review of cost-effectiveness analyses of elective THA and TKA that were published between January 1980 and February 2012. To limit our search to high-quality publications, we selected among papers included in the Cost-Effectiveness Analysis Registry (created by the Center for the Evaluation of Value and Risk in Health); we augmented our search with papers listed in PubMed.  Only papers reporting incremental cost-effectiveness ratios (ICERs) as the change in cost over the change in quality-adjusted life expectancy between alternative treatment strategies were included. We abstracted the analysis perspective, time horizon, and ICERs (converted to 2011 USD) from the selected papers.

Results: Seven TKA and six THA studies met the criteria for our review. All economic evaluations of TKA were published between 2006 and 2012, whereas THA studies spanned 1996 to 2008. Out of the 13 included studies, four assumed the societal perspective, eight the payer perspective, and in one study the perspective was unclear. Seven studies spanned the lifetime horizon. Studies of both THA and TKA that have assumed a societal perspective and lifetime horizon have estimated ICERs below $50,000/QALY in cohorts with  mean age 69 years or older. Hip resurfacing has been shown to be dominated by THA (more costly, less effective) in a cohort aged 65 years and younger. Unicondylar knee arthroplasty (UKA) has been shown to be cost effective or cost-saving among cohorts of mean age 65 – 75 years.

Conclusion: THA and TKA have been found to be highly cost-effective in a number of high-quality studies. Further analyses of the cost-effectiveness of alternative surgical options, including knee osteotomy, among young individuals are needed.  Future economic evaluations should address the expanding indications of THA and TKA to younger, more physically active individuals.

Comparison*

Paper

Perspective

ICER

($/QALY; 2011 USD)

Time Horizon

Total Hip Arthroplasty 

 

 

THA vs. No Surgery

Chang

1996

Societal

$10,402

Lifetime

Improved Implant (reduced revision rate, increased cost) vs. Standard Implant

Briggs

1998

Payer

$17,671

Lifetime

Briggs

2004

Payer

cost saving

60 yrs

Bozic

2006

Not clear

cost saving

Lifetime

THA vs. Hip Resurfacing

McKenzie

2003

Payer

THA dominates

20 yrs

Cementless vs. Cement

Marinelli

2008

Payer

Neither option clearly better

Lifetime

Total Knee Arthroplasty 

 

 

Computer Assisted Surgery vs. TKA

Dong

2006

Payer

cost saving

10 yrs

Novak

2007

Payer

$54,234

15 yrs

UKA vs. TKA

Slover

2006

Payer

cost saving

Lifetime

Soohoo

2006

Societal

$458

Lifetime

TKA vs. UKA

Xie

2010

Societal

$71,731

2 yrs

TKA vs. No Surgery

Losina

2009

Societal

$11,548

Lifetime

Dakin

2012

Payer

$12,566

5 yrs

*The first strategy listed is the primary intervention studied, and the second strategy is the reference comparator; that is, ICERs refer to the cost-effectiveness of the first treatment option listed.

 


Disclosure:

M. E. Daigle,
None;

A. M. Weinstein,
None;

J. N. Katz,
None;

E. Losina,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-cost-effectiveness-of-total-joint-arthroplasty-a-systematic-review-of-published-literature/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology